NLM Logo

protocol 8001 MeSH Supplementary Concept Data 2023


MeSH Supplementary
protocol 8001
Unique ID
C054950
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C054950
Entry Term(s)
P-8001
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Asparaginase
Cyclophosphamide
Cytarabine
Hydrocortisone
Methotrexate
Prednisone
Vincristine
Mercaptopurine
Frequency
1
Note
chemotherapy regimen consisting of above cpds; used in the therapy of non-Hodgkin's lymphoma in children
Source
Am J Pediatr Hematol Oncol 1987;9(4):356
Date of Entry
1988/03/24
Revision Date
2000/11/30
protocol 8001 Preferred
page delivered in 0.005s